Detalhe da pesquisa
1.
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies.
Haematologica
; 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38268449
2.
Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
Lancet Oncol
; 20(8): 1109-1123, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31301962
3.
Acute lymphoblastic leukemia.
J Natl Compr Canc Netw
; 10(7): 858-914, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22773801
4.
Diffuse large B-cell lymphoma: current strategies and future directions.
Cancer Control
; 19(3): 204-13, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22710896
5.
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 28(11): 2237-2247, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363301
6.
Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial.
Cancers (Basel)
; 12(10)2020 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33076423
7.
A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis.
J Hematol Oncol
; 11(1): 122, 2018 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30249277
8.
Outcome of diffuse large B-Cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data.
Clin Lymphoma Myeloma Leuk
; 11(3): 257-60, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21658652
9.
Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review.
Leuk Res
; 35(12): 1571-7, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21752466